Isatis Root Granules
Natural health product licensed in Canada
- Licence holder
- Beijing Kingbird Pharmaceutical Technology Development Co.,Ltd.
- NPN or DIN-HM
- 80063820
- Status
- Active licence
- Licence date
- 3 September 2015
- Revision date
- 9 November 2021
- Form
- Granules
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Isatis tinctoria Source : Racine Extract : Matériel brut sec Extraction ratio : 9.333:1 Dry plant equivalent : 14 Grammes | 1.5 Grammes | Not calculated |
Non-medicinal ingredients
Sucrose, Dextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 14 years | minimum: 5 Grammes ; maximum: 10 Grammes | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Used for swollen sore throat, dryness in mouth and throat caused by infection of the upper respiratory tract, such as tonsillitis, laryngitis. Helps to relieve the symptoms of influenza, and improve the organism immunity. Traditionally used as an antiviral.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are allergy to this product, please do not use this product.
- Précautions et mises en garde
Avoid alcohol and tobacco, spicy food. Patients with diabetes, high blood pressure, heart disease, liver disease, nephropathy and other severe chronic diseases should take this product under guidance of health care practitioner. Children, pregnant women, lactating women, old and weak people should take medicine under guidance of health care practitioner. Consult a health care practitioner if symptoms persist or worsen. Adults should keep the medicines properly and children must take the product under the adult supervision. Drug interactions may occur when taking with other medicines, consult a health care practitioner.
Source
Official Health Canada record, licence 80063820
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging